Efficacy of a novel small molecule MER receptor tyrosine kinase inhibitor in B-RAF wild-type and B-RAF mutant melanoma cell lines

被引：1
|
作者：
Teodorovic, Lenka S. [1 ]
Carrico, Jacqueline [1 ]
DeRyckere, Deborah [1 ]
Zhang, Weihe [2 ]
Wang, Xiaodong [2 ]
Frye, Stephen [2 ]
Eckhardt, S. Gail [1 ]
Earp, H. Shelton [2 ]
Graham, Douglas K. [1 ]
机构：
[1] Univ Colorado Denver, Aurora, CO USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-730
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
730
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The synthesis of a novel inhibitor of B-Raf kinase
    Denni-Dischert, D
    Marterer, W
    Bänziger, M
    Yusuff, N
    Batt, D
    Ramsey, T
    Geng, P
    Michael, W
    Wang, RMB
    Taplin, F
    Versace, R
    Cesarz, D
    Perez, LB
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2006, 10 (01) : 70 - 77
  • [2] Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UAI-201
    Lee, Michael
    Ahn, Jun-Ho
    Ahn, Soon Kil
    FASEB JOURNAL, 2012, 26
  • [3] Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152
    Kim, Yun-Ki
    Ahn, Soon Kil
    Lee, Michael
    CANCER LETTERS, 2012, 320 (02) : 215 - 224
  • [4] Apoptotic response of mutant B-RAF human melanoma cells to a B-RAF inhibitor involves increased splicing production of BimS
    Zhang, Xu Dong
    Jiang, Chen Chen
    Lai, Fritz
    Croft, Amanda
    Tay, Kwang Hong
    Thorne, Rick F.
    Becker, Therese
    Rizos, Helen
    Hersey, Peter
    CANCER RESEARCH, 2010, 70
  • [5] MECHANISMS OF RESISTANCE TO THE B-RAF INHIBITOR ZELBORAF IN FOUR MELANOMA CELL LINES
    Garg, E.
    Kong, X.
    Shi, H.
    Moriceau, G.
    Lo, R. S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 147 - 147
  • [6] VEMURAFENIB B-raf Kinase Inhibitor Oncolytic
    Puzanov, I.
    Flaherty, K. T.
    Sosman, J. A.
    Grippo, J. F.
    Su, F.
    Nolop, K.
    Lee, R. J.
    Bollag, G.
    DRUGS OF THE FUTURE, 2011, 36 (03) : 191 - 199
  • [7] The genesis of Zelboraf: Targeting mutant B-Raf in melanoma
    Davis, Matthew J.
    Schlessinger, Joseph
    JOURNAL OF CELL BIOLOGY, 2012, 199 (01): : 15 - 19
  • [8] Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
    Garnett, MJ
    Rana, S
    Paterson, H
    Barford, D
    Marais, R
    MOLECULAR CELL, 2005, 20 (06) : 963 - 969
  • [9] Inactivation of Receptor Tyrosine Kinases Overcomes Resistance to Targeted B-RAF Inhibitors in Melanoma Cell Lines
    O. O. Ryabaya
    A. A. Malysheva
    Yu. A. Khochenkova
    E. Sh. Solomko
    D. A. Khochenkov
    Molecular Biology, 2018, 52 : 398 - 405
  • [10] Inactivation of Receptor Tyrosine Kinases Overcomes Resistance to Targeted B-RAF Inhibitors in Melanoma Cell Lines
    Ryabaya, O. O.
    Malysheva, A. A.
    Khochenkova, Yu. A.
    Solomko, E. Sh.
    Khochenkov, D. A.
    MOLECULAR BIOLOGY, 2018, 52 (03) : 398 - 405
12345